Primary Recipient

YALE UNIVERSITY

Amount

$188,870.00

Award Date

9/30/2009

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

The primary goal of this supplementary application is to develop a potent beta-peptide agonist of the GLP-1 receptor, a validated target for the treatment of type 2 diabetes. The experimental plan builds solidly on a foundation of results obtained in our